Delivery Order SPE2DB22D3016-SPE2DB24FAAH9
- Not listed
- This federal contract award, valued at $21,185.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under DLA's larger Indefinite Delivery Contract (IDC) with Cencora, Inc., valued at up to $999,999,999.00 and running through December 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $11,558.67 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of a pharmaceutical product, specifically RINVOQ ER 15 MG TABLET, to support military and veteran healthcare programs. This IDC, valued up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products and medical supplies. The contract, valued at $5,611.45, covers the delivery of Rinvoq ER 15 mg tablets through February 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,452.14 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that was awarded to Cencora, Inc. through the DLA Troop Support Medical program. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical and medical supply distribution services. The $3,184.32 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which was awarded to Cencora, Inc. and runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $39,597.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a...
- This federal contract award, with a ceiling value of $27,510.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and other critical medical commodities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $24,122.49, is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication. The IDC held by Cencora, Inc. is valued at up to $999,999,999.00 and runs through December 2025, serving as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $1,014.20, is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,653.50, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAAH9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The contract, valued at $13,640.52, is a delivery order under an Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, worth up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award covers the delivery of RINVOQ ER 30 MG TABLET, a prescription medication, with a completion date of October 17, 2023. This contract is part of Cencora, Inc.'s broader role as a critical supplier of essential pharmaceutical and medical products to various federal government agencies, including the Department of Defense and the Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 10/16/23 |